Swiss Rockets AG Acquires Complete Genomics 

Swiss Rockets AG Acquires Complete Genomics 

Swiss Rockets AG, based in Basel, Switzerland, announced on February 23 that it entered into a definitive agreement to acquire Complete Genomics, Inc.   Complete Genomics is a leader in whole human genomic sequencing, which is used by research centers to conduct medical research that, in the future, is expected to be used to improve both prevention and treatment of disease. Since its founding in 2005, the company has been at the forefront of high-throughput, cost-effective sequencing innovation, supporting more than 10,900 scientific publications worldwide.  Swiss Rockets is a portfolio of biotechnology companies. Its portfolio includes radioligand therapies, small molecules... Read More »
Specialty1 Partners Announces Second Acquisition of 2025 

Specialty1 Partners Announces Second Acquisition of 2025 

Triumphant Transition Partners announced that it acted as an advisor to Dr. Francisco Perez as he joined Specialty1 Partners.  The practice of Dr. Francisco Perez is based in Edinburg, Texas. Dr. Perez, an oral and maxillofacial surgeon, is the only physician on staff.  Specialty1 Partners, backed by private equity firm VSS Capital Partners, is the parent company of dental-surgical partnerships Endo1 Partners, Perio1 Partners and OS1 Partners. It maintains and scales practices to optimize performance and turn goals into reality. Specialty1 has established partnerships with more than 225 practices and has a network of more than 350 specialists across 28 states.  The financial... Read More »
Gilead Inks $7.8 Billion Deal to Purchase Arcellx

Gilead Inks $7.8 Billion Deal to Purchase Arcellx

On February 23, Gilead Sciences, Inc. announced that it has entered into a definitive agreement to acquire Arcellx, Inc. Under the terms of the agreement, Arcellx shareholders will receive $115 per share in cash at closing plus one contingent value right of $5 per share, representing an implied equity value of $7.8 billion payable at closing. Arcellx is a clinical-stage biotechnology company focused on delivering a new class of immunotherapies for patients with cancer and other incurable diseases. Arcellx’s lead pipeline candidate, anitocabtagene autoleucel (anito-cel), is currently in a Phase 2 pivotal trial for patients with relapsed or refractory multiple myeloma. According to its most... Read More »
Enhabit to be Acquired by Kinderhook Industries for $1.1 Billion

Enhabit to be Acquired by Kinderhook Industries for $1.1 Billion

Enhabit, Inc. announced on February 23 that it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC, a middle market private equity firm. Kinderhook Industries is acquiring Enhabit in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Enhabit is a leading national home health and hospice provider with headquarters in Dallas, Texas. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 249 home health locations and 117 hospice locations across 34 states. According to its most recent annual filing, Enhabit generated approximately $1.03 billion in... Read More »
Center for Social Dynamics Expands Footprint in Southwest With Acquisition

Center for Social Dynamics Expands Footprint in Southwest With Acquisition

Center for Social Dynamics (CSD) announced that it is strengthening its footprint in the Southwest with its latest addition. The company is acquiring Behavior Change Institute (BCI) in Alamogordo, New Mexico. BCI is an autism services provider specializing in diagnostic evaluations, early intervention and evidence-based behavioral therapies. BCI has earned a reputation as one of New Mexico’s most trusted autism care providers, serving families across urban and rural communities and playing a pivotal role in reducing barriers to diagnosis and treatment. Founded in 2012, CSD is a provider of evidence-based autism and behavioral health services, built around a clinical curriculum... Read More »
Hims & Hers Announces Agreement to Acquire Eucalyptus

Hims & Hers Announces Agreement to Acquire Eucalyptus

Hims & Hers Health, Inc., the leading health and wellness platform, announced on February 19 that it has entered into a definitive agreement to acquire Eucalyptus. As its U.S. business continues to grow, Hims & Hers will be positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the United Kingdom, Germany and Canada. Founded in 2019, Eucalyptus builds and operates a network of digital healthcare companies. The company has facilitated nearly two million consultations across Australia, the United Kingdom, Germany, Japan and Canada. Hims & Hers is a multi-specialty telehealth platform based in San Francisco, California. Hims... Read More »
Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront

Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront

Tactile Systems Technology, Inc. announced that it is acquiring LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones. Founded in 2014, LymphaTech is a privately held medical technology company pioneering a digital, three-dimensional full body measurement and monitoring platform designed specifically for lymphedema. Tactile Systems Technology is a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home. The company develops and markets at-home therapies for people suffering from underserved, chronic conditions,... Read More »

LevinPro HC Stat of the Week: Most Active Private Equity Firms

In the final preview of our 2026 Health Care Services Acquisition Report, we’re placing a spotlight on the most active private equity firms in the healthcare market. In the past five years, no private equity firm has been more involved in the healthcare M&A market than Charlesbank Capital Partners. The firm and its portfolio companies have announced 172 transactions over the past five years, according to transaction data captured in the LevinPro HC platform. It was founded in 1998 and currently has $22 billion in total assets, according to its website. Of those 172 deals, Charlesbank’s portfolio company, MB2 Dental Solutions, is responsible for nearly all of them (165). Founded... Read More »
TA Associates Sells PrimeRx to RedSail Technologies 

TA Associates Sells PrimeRx to RedSail Technologies 

William Blair announced that it acted as an advisor to PrimeRx throughout its acquisition by RedSail Technologies. The seller was TA Associates, who initially invested in PrimeRx in 2021.  Having closed on February 5, 2026, this transaction marked William Blair’s second signed or closed advisory deal in healthcare technology in 2026. Terms were not disclosed.  PrimeRx is a provider of pharmacy management software. The company’s software and services enable pharmacists to manage all clinical and operational aspects of their business, including prescription management, point-of-sale, signature capture and document/inventory management.  RedSail Technologies offers... Read More »
Imagen Dental Partners Announces Its First Deal of the Year  

Imagen Dental Partners Announces Its First Deal of the Year  

On February 17, Imagen Dental Partners announced its first acquisition of the year with the purchase of Campbell Dental. Terms of the deal were not disclosed.  Based in Cedar Park, Texas, Campbell Dental offers the full scope of dental care. It is run by Dr. Jarrod Campbell, who is supported by a team of assistants.  Imagen Dental is a dental partnership organization founded in 2020 that joins with dental practices, invests in them and supports their growth. Imagen Dental Partners supports practices in 15 states.   According to data captured in the LevinPro, this marks the 81st Physician Medical Group (PMG) transaction of the year, and the 34th in the dental specialty.... Read More »